The clonoSEQ® Watch Registry

• The clonoSEQ® Watch Registry

• Real World Observational Study Using clonoSEQ® Next Generation Sequencing in Hematologic Malignancies: The 'Watch' Registry

l

This is a prospective, multicenter, observational study of adult patients with a diagnosis of acute lymphoblastic leukemia (ALL), multiple myeloma (MM), chronic lymphocytic leukemia (CLL), or non-Hodgkin lymphoma (NHL). This study will enroll up to 528 patients in up to 50 sites in the United States and collect data with regard to use of the clonoSEQ MRD assay in the management of lymphoid malignancies.

Diagnostic Test

clonoSEQ Assay

Sponsor

Adaptive Biotechnologies

---

ClinicalTrials.gov Identifier: NCT04545333

Official Title: Real World Observational Study Using clonoSEQ® Next Generation Sequencing in Hematologic Malignancies: The 'Watch' Registry

First Posted: September 11, 2020

Click here for details on ClinicalTrials.gov

---

- Multiple Locations

---

Locations

United States, California

United States, Colorado

United States, District of Columbia

United States, Florida

United States, Illinois

United States, Louisiana

United States, Maryland

United States, Missouri

United States, North Carolina

United States, Oregon

United States, Pennsylvania

United States, South Carolina

United States, Washington